Prulifloxacin has a reduced effect on the QTc interval compared to other fluoroquinolones and may be a safer choice for patients with pre-existing risk factors for arrhythmia.<ref name="repolarization5">{{cite journal | vauthors = Rosignoli MT, Di Loreto G, Dionisio P | title = Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects | journal = Clinical Drug Investigation | volume = 30 | issue = 1 | pages = 5–14 | year = 2010 | pmid = 19995094 | doi = 10.2165/11319400-000000000-00000 }}</ref><ref>{{cite journal | vauthors = Malik M | title = Does the Prulifloxacin ECG Study Prove Cardiac Safety of the Drug? | journal = Clinical Drug Investigation | volume = 30 | issue = 1 | pages = 1–3 | year = 2010 | pmid = 19995093 | doi = 10.2165/11319780-000000000-00000 }}</ref>

 
*Warfarin:  May enhance the effects of oral anticoagulants such as warfarin and its derivatives.<ref name="cipladoc.com"/>
